Perfil
En la actualidad, Mark Hernon ocupa el cargo de Director de Información y Vicepresidente Senior de Biogen, Inc. Se licenció y se graduó en el Rensselaer Polytechnic Institute y obtuvo un MBA en la Lally School of Management & Technology.
Antiguos cargos conocidos de Mark Hernon.
| Empresas | Cargo | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/09/2022 |
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Formación de Mark Hernon.
| Rensselaer Polytechnic Institute | Graduate Degree |
| The Lally School of Management & Technology | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Hernon
